Dr. Hettich is also a non-executive director of Hettich India Private Limited and managing partner of his own holding group, Dr. Hettich Beteiligungen GmbH, which has investments in companies such as EWIKON, Halemeier, and the educational company "das Forscherhaus", among other entrepreneurial commitments. Dr. Hettich is also a member of the advisory and supervisory boards of Jowat, Peter Lacke, FSB and Georg Nordmann Holding.
Well-known members complete the advisory board
Chiratae Ventures' Global Advisory Board includes Ratan Tata (Chairman Emeritus of Tata Sons), Kris Gopalakrishnan (Co-Founder of Infosys), Bruno E. Raschle, (Founder, Managing Director and Non-Executive Vice Chairman of Schroder) and Manish Choksi (Non-Executive Vice Chairman of Asian Paints). Chiratae India's Advisory Board includes Dr Ferzaan Engineer, a multi-entrepreneur in healthcare and founder of Cytecare Cancer Hospitals, an Indian hospital network specialising in cancer treatment.
Vision and mission - international exchange is key to success
"The Indian startup scene is one of the fastest growing in the world. Chiratae Ventures plays a key role in building a sustainable startup landscape and developing industry-leading brands," comments Dr Andreas Hettich on joining Chiratae's global advisory board. "I am delighted to be working with the company at this exciting time when we are entering a new normal and can join outstanding Indian entrepreneurs in their journey to success by picking up many innovative ideas and systematically taking them forward."
Sudhir Sethi, Founder and Chairman of Chiratae Ventures is looking forward to their cooperation in the Global Advisory Board. "Dr. Hettich's unique business experience and vision will further strengthen our mission by sharing our knowledge and strategic insights across all sectors. We believe our portfolio companies can benefit tremendously from his unique perspective and years of business experience to succeed internationally in the future."